|Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards|
S Vasikaran, R Eastell, O Bruyère, AJ Foldes, P Garnero, A Griesmacher, ...
Osteoporosis international 22 (2), 391-420, 2011
|The assessment of vertebral deformity: a method for use in population studies and clinical trials|
EV McCloskey, TD Spector, KS Eyres, ED Fern, N O'rourke, S Vasikaran, ...
Osteoporosis International 3 (3), 138-147, 1993
|Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis|
SA Khan, JA Kanis, S Vasikaran, WF Kline, BK Matuszewski, ...
Journal of Bone and Mineral Research 12 (10), 1700-1707, 1997
|International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis|
S Vasikaran, C Cooper, R Eastell, A Griesmacher, HA Morris, T Trenti, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 49 (8), 1271-1274, 2011
|B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo …|
Hankey GJ, Eikelboom JW, Baker RI, Gelavis A, Hickling SC, Jamrozik K, van ...
Lancet Neurol 9, 855-865, 2010
|Methylenetetrahydrofolate reductase gene and coronary artery disease|
FM van Bockxmeer, CDS Mamotte, SD Vasikaran, RR Taylor
Circulation 95 (1), 21-23, 1997
|Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir|
D Nolan, R Upton, E McKinnon, M John, I James, B Adler, G Roff, ...
Aids 15 (10), 1275-1280, 2001
|Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis|
J Lee, S Vasikaran
Annals of laboratory medicine 32 (2), 105-112, 2012
|Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays|
P Glendenning, M Taranto, JM Noble, AA Musk, C Hammond, ...
Annals of clinical biochemistry 43 (1), 23-30, 2006
|Bisphosphonates: an overview with special reference to alendronate|
Annals of clinical biochemistry 38 (6), 608-623, 2001
|A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life|
OP Almeida, NT Lautenschlager, S Vasikaran, P Leedman, A Gelavis, ...
Neurobiology of aging 27 (1), 141-149, 2006
|A meta-analysis of reference markers of bone turnover for prediction of fracture|
H Johansson, A Odén, JA Kanis, EV McCloskey, HA Morris, C Cooper, ...
Calcified tissue international 94 (5), 560-567, 2014
|Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate|
NP O'Rourke, EV McCloskey, S Vasikaran, K Eyres, D Fern, JA Kanis
British journal of cancer 67 (3), 560-563, 1993
|Association of cardiovascular risk factors and disease with depression in later life|
OP Almeida, L Flicker, P Norman, GJ Hankey, S Vasikaran, ...
The American Journal of Geriatric Psychiatry 15 (6), 506-513, 2007
|A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone|
JP Walsh, LC Ward, GO Stewart, RK Will, RA Criddle, RL Prince, ...
Bone 34 (4), 747-754, 2004
|Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia|
NT Lautenschlager, L Flicker, S Vasikaran, P Leedman, OP Almeida
The American Journal of Geriatric Psychiatry 13 (8), 731-734, 2005
|Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis|
Critical reviews in clinical laboratory sciences 45 (2), 221-258, 2008
|Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life|
OP Almeida, L Flicker, NT Lautenschlager, P Leedman, S Vasikaran, ...
Neurobiology of aging 26 (2), 251-257, 2005
|Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol|
P Glendenning, GT Chew, HM Seymour, MJ Gillett, PR Goldswain, ...
Bone 45 (5), 870-875, 2009
|Quality assessment of interpretative commenting in clinical chemistry|
EM Lim, KA Sikaris, J Gill, J Calleja, PE Hickman, J Beilby, SD Vasikaran
Clinical chemistry 50 (3), 632-637, 2004